Genomtec S.A. (GMT) — Capital Reinvestment Ratio

Latest as of December 2024: 0.05x

Genomtec S.A. (GMT) has a Capital Reinvestment Ratio of 0.05x as of December 2024, meaning it reinvests 0% of its operating cash flow (zł925.00K) in capital expenditures (zł45.00K). See how leveraged is Genomtec S.A.'s balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

zł925.00K

PLN

Capital Expenditures

zł45.00K

PLN

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Genomtec S.A. (None–None)

Year-by-year Capital Reinvestment Ratio for Genomtec S.A. from None to None. For live market cap and broader valuation context, see GMT stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (PLN)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow